Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion
Thursday, March 13, 2025
Home »
World News
» Mallinckrodt to Take Over Endo in Deal Valued at $6.7 Billion
Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion